scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0140-6736(79)91841-5 |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0140673679918415?httpAccept=text/plain |
https://api.elsevier.com/content/article/PII:S0140673679918415?httpAccept=text/xml | ||
P698 | PubMed publication ID | 86882 |
P2093 | author name string | D. Doyle | |
J. A. Thomson | |||
J. G. Ratcliffe | |||
P. Macpherson | |||
E. A. Cowden | |||
G. M. Teasdale | |||
P2860 | cites work | Transient Bitemporal Hemianopsia During Pregnancy After Treatment of Galactorrhea-Amenorrhea Syndrome with Bromocriptine | Q28330320 |
Functional evaluation of prolactin secretion: a guide to therapy | Q34494876 | ||
A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma | Q36719102 | ||
Serum Prolactin Response to Thyrotropin-Releasing Hormone and Metoclopramide in Patients with Prolactin-Secreting Tumors before and after Transsphenoidal Surgery | Q39724975 | ||
Clinical neuroendocrinology | Q40098176 | ||
Transsphenoidal microsurgery for pituitary tumors associated with hyperprolactinemia | Q40153114 | ||
Nomifensine: Diagnostic Test in Hyperprolactinemic States* | Q40468038 | ||
Pituitary Autonomy in Hyperprolactinemic Secondary Amenorrhea: Results of Hypothalamic-Pituitary Testing | Q41250550 | ||
Clinical and endocrine features of hyperprolactinaemic amenorrhoea | Q42443937 | ||
Basal and TRH-stimulated prolactin in patients with pituitary tumours | Q42443987 | ||
Borderline variants of the normal pituitary fossa | Q45022148 | ||
Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumours | Q48196801 | ||
Galactorrhea: a study of 235 cases, including 48 with pituitary tumors | Q48306540 | ||
Long-term Treatment of Galactorrhoea and Hypogonadism with Bromocriptine | Q48555334 | ||
Neuroendocrine Dysfunction in Galactorrhea-Amenorrhea After Oral Contraceptive Use | Q66961276 | ||
Prolactin secretion in sixty-five patients with galactorrhea | Q67268702 | ||
Hyperprolactinaemia in renal disease | Q67403297 | ||
Treatment of patients with prolactinomas | Q67459568 | ||
Prolactin-secreting pituitary microadenomas: roentgenologic diagnosis | Q69818026 | ||
P433 | issue | 8127 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1155-1158 | |
P577 | publication date | 1979-06-01 | |
1979-06-02 | |||
P1433 | published in | The Lancet | Q939416 |
P1476 | title | Tests of prolactin secretion in diagnosis of prolactinomas | |
P478 | volume | 1 |
Q36716713 | A practical approach to the investigation of the hyperprolactinaemic patient |
Q69846459 | Abnormal responses to vasoactive intestinal peptide and corticotropin releasing hormone during the spontaneous remission of Cushing's disease |
Q41600845 | Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function |
Q42861742 | Assessment of pituitary function. |
Q72477356 | Autonomous prolactin secretion in schizophrenic male on long-term neuroleptic therapy |
Q42745258 | Computed tomographic abnormalities of the pituitary in hyperprolactinaemic women. |
Q54099399 | Cushing's disease with hyperprolactinaemia treated by transsphenoidal hypophysectomy |
Q33614609 | Diagnostic value of thyrotropin-releasing-hormone stimulation in patients with pituitary tumor. |
Q42436308 | Differential effects of acute DA receptor blockade with domperidone on LH and TSH release in patients with hyperprolactinemia |
Q47824731 | Fansidar resistant falciparum malaria in Indonesia |
Q36717238 | Galactorrhoea, hyperprolactinaemia, and pituitary adenoma presenting during metoclopramide therapy |
Q42446070 | Heterogeneity of prolactin responses to oestradiol benzoate in women with prolactinomas |
Q69510562 | High-resolution computed tomography in pituitary microadenoma: is seeing believing? |
Q50124492 | Hyperflexion cervical cord injury in a children's car seat |
Q81060204 | Hyperprolactinemia |
Q38724656 | Hyperprolactinemia: neuroendocrine and diagnostic aspects |
Q40140971 | Investigation of hypothalamic-pituitary disease |
Q42459987 | Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests |
Q34490393 | Management of selected patients with hyperprolactinaemia by partial hypophysectomy |
Q34256619 | Management of the Hirsute Woman |
Q48555216 | Multiple intracranial metastases from a prolactin secreting pituitary tumour |
Q66705091 | Nomifensine test for investigation of hyperprolactinaemia |
Q70463287 | Nomifensine, TRH and insulin-induced hypoglycemia tests in the diagnosis of prolactinomas |
Q42491895 | Perifusion studies of bromocriptine-treated and untreated macroprolactinomas: effects of dopamine, bromocriptine and TRH. |
Q58553376 | Pharmacokinetics and Pharmacodynamics of Ropinirole in Patients with Prolactinomas |
Q72405495 | Pituitary tumors |
Q69936731 | Prolactin response to thyrotropin-releasing hormone (TRH) in patients with hypothalamic-pituitary disease |
Q40090274 | Prolactin-Lowering and -Releasing Drugs Mechanisms of Action and Therapeutic Applications |
Q42359810 | Prolactinoma: a question of rational treatment |
Q52096963 | Psychiatric and social aspects of premenstrual complaint. |
Q42464882 | Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia |
Q40211156 | Surgical management of pituitary adenoma. |
Q42477898 | TRH raises cytosolic Ca2+ in human adenomatous lactotrophs |
Q66704102 | TRH test for prolactinoma |
Q70681763 | Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone |
Q39467835 | The circadian rhythms of thyrotrophin and prolactin secretion |
Q42527843 | The inability of dynamic tests of prolactin and TSH secretion to differentiate between tumorous and non-tumorous hyperprolactinemia |
Q43954553 | The interaction of trh and dopaminergic mechanisms in the regulation of stimulated prolactin release in man. |
Q42456573 | The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour |
Q69057400 | The natural history of untreated microprolactinomas |
Q47210992 | The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery |
Q40283167 | The use of bromocriptine in obstetrics and gynecology. |
Q42463352 | The value of the thyrotropin-releasing hormone test in patients with prolactin-secreting pituitary tumors and suprasellar non-pituitary tumors. |
Q34490406 | Treatment of presumed prolactinoma by transsphenoidal operation: early and late results. |
Q71353674 | Trends in the management of prolactinomas |
Q41573466 | Twenty-four-hour prolactin secretory patterns in women with galactorrhea, normal menses, normal random prolacting levels and abnormal sellar tomograms |
Search more.